search
Back to results

Wavefront-guided vs. Topography-guided LASIK

Primary Purpose

Myopia

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Wavefront-guided LASIK
Wavefront-guided
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia focused on measuring wavefront-guided, topography-guided, LASIK

Eligibility Criteria

22 Years - 59 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria.

  • Subjects ages 22 and older with healthy eyes. Nearsightedness between -1.00 diopters and -9.00 diopters.
  • Subjects with less than or equal to 3.00 diopters of astigmatism.

Exclusion criteria.

  • Subjects under the age of 22.
  • Subjects with excessively thin corneas.
  • Subjects with topographic evidence of keratoconus.
  • Subjects with ectactic eye disorders.
  • Subjects with autoimmune diseases.
  • Subjects who are pregnant or nursing.
  • Subjects must have similar levels of nearsightedness in each eye. They cannot be more than 1.5 diopter of difference between eyes.
  • Subjects with more than 3.00 diopters of astigmatism
  • Subjects must have similar levels of astigmatism in each eye. They cannot have more than 1.00 diopters of difference between eyes.

Sites / Locations

  • Stanford University School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Wavefront-guided LASIK

Topography-guided LASIK

Arm Description

Wavefront-guided LASIK for myopia and myopic astigmatism

Topography-guided LASIK for myopia and myopic astigmatism

Outcomes

Primary Outcome Measures

Percentage of eyes achieving uncorrected visual acuity
Percentage of eyes achieving an uncorrected visual acuity of 20/40, 20/25 ,20/20, 20/16, 20/12.5 and 20/10 at post-operative month twelve

Secondary Outcome Measures

Percentage of eyes with a change in two or more lines of corrected visual acuity
Percentage of eyes gaining or losing two or more lines of corrected visual acuity Percentage of eyes gaining or losing 2 or more lines of corrected distance visual acuity
Predictability
Percentage of eyes within +/- 0.50 and +/- 1.00 diopters of the intended corrected
Patient Quality of Vision
Percentage of patients preferring the eye that underwent either Wavefront-guided or Topography-guided LASIK
Change in corneal epithelial thickness
We will be measuring the average change in central corneal epithelial thickness from preoperative to post-operative month12 in eyes undergoing Wavefront-guided LASIK and Topography-guided LASIK

Full Information

First Posted
October 17, 2022
Last Updated
April 11, 2023
Sponsor
Stanford University
search

1. Study Identification

Unique Protocol Identification Number
NCT05588882
Brief Title
Wavefront-guided vs. Topography-guided LASIK
Official Title
A Prospective Randomized Comparison of Topography-Guided LASIK Surgery to Wavefront-Guided LASIK Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 19, 2022 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study is comparing outcomes of wavefront-guided LASIK to topography-guided LASIK in a randomized contralateral fellow eye study in myopic participants.
Detailed Description
The purpose of the study is to compare the results of wavefront-guided LASIK surgery to topography-guided LASIK surgery in participants with nearsightedness with or without astigmatism Three FDA-approved laser devices are being used for the study. Two excimer lasers are being used for the study. The excimer laser is used to perform the reshaping of the cornea under a LASIK flap to correct nearsightedness, farsightedness and astigmatism. The two lasers being utilized are the Johnson and Johnson Visx CustomVue excimer laser and the Alcon Allegretto laser in the study. Both have received FDA-approval via a PMA pathway. One femtosecond laser is being used in the study. The femtosecond laser is used to create the LASIK flap during the first part of the LASIK procedure. The Intralase iFS150 femtosecond laser is being used in the study. The femtosecond laser received FDA- approval via a 510k pathway. All three lasers are being used according to their approved indications.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia
Keywords
wavefront-guided, topography-guided, LASIK

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants contribute one eye to each study arm
Masking
Participant
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Wavefront-guided LASIK
Arm Type
Active Comparator
Arm Description
Wavefront-guided LASIK for myopia and myopic astigmatism
Arm Title
Topography-guided LASIK
Arm Type
Active Comparator
Arm Description
Topography-guided LASIK for myopia and myopic astigmatism
Intervention Type
Procedure
Intervention Name(s)
Wavefront-guided LASIK
Other Intervention Name(s)
Topography-guided LASIK
Intervention Description
Topography-guided utilizes topography mapping to perform the ablation
Intervention Type
Procedure
Intervention Name(s)
Wavefront-guided
Intervention Description
Wavefront-guided utilizes aberrometry to perform the ablation
Primary Outcome Measure Information:
Title
Percentage of eyes achieving uncorrected visual acuity
Description
Percentage of eyes achieving an uncorrected visual acuity of 20/40, 20/25 ,20/20, 20/16, 20/12.5 and 20/10 at post-operative month twelve
Time Frame
One year
Secondary Outcome Measure Information:
Title
Percentage of eyes with a change in two or more lines of corrected visual acuity
Description
Percentage of eyes gaining or losing two or more lines of corrected visual acuity Percentage of eyes gaining or losing 2 or more lines of corrected distance visual acuity
Time Frame
One year
Title
Predictability
Description
Percentage of eyes within +/- 0.50 and +/- 1.00 diopters of the intended corrected
Time Frame
One year
Title
Patient Quality of Vision
Description
Percentage of patients preferring the eye that underwent either Wavefront-guided or Topography-guided LASIK
Time Frame
One year
Title
Change in corneal epithelial thickness
Description
We will be measuring the average change in central corneal epithelial thickness from preoperative to post-operative month12 in eyes undergoing Wavefront-guided LASIK and Topography-guided LASIK
Time Frame
One year

10. Eligibility

Sex
All
Gender Based
Yes
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria. Subjects ages 22 to 59with healthy eyes. Nearsightedness between -1.00 diopters and -9.00 diopters. Subjects with less than or equal to 3.00 diopters of astigmatism. Exclusion criteria. Subjects under the age of 22 and over the age of 59 Subjects with excessively thin corneas. Subjects with topographic evidence of keratoconus. Subjects with ectactic eye disorders. Subjects with autoimmune diseases. Subjects who are pregnant or nursing. Subjects must have similar levels of nearsightedness in each eye. They cannot be more than 1.5 diopter of difference between eyes. Subjects with more than 3.00 diopters of astigmatism Subjects must have similar levels of astigmatism in each eye. They cannot have more than 1.00 diopters of difference between eyes.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Edward E Manche, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University School of Medicine
City
Palo Alto
State/Province
California
ZIP/Postal Code
94303
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Wavefront-guided vs. Topography-guided LASIK

We'll reach out to this number within 24 hrs